The American-Uzbekistan Chamber of Commerce (AUCC) seeks to promote trade and investment ties, cultural exchanges and bonds of friendship between the United States of America and the Republic of Uzbekistan. In performing these functions, the AUCC places primary emphasis on serving the needs and interests of its members.

Interview with AUCC Chairperson Carolyn Lamm Before 2012 Uzbekistan-US Annual Business Forum

Get Flash to see this player.

» AUCC events

» Contact us


Cerebain Biotech Corp. Announces Engagement of IDC Consulting for Representation in Uzbekistan

24 June 2013

Cerebain Biotech Corp. ("Cerebain" or "the Company"), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced today that it has engaged IDC Consulting to represent the Company in Uzbekistan for the purpose of Clinical Testing of the Company's Medical Device for the treatment of Alzheimer's Disease utilizing the Omentum. IDC Consulting will serve as the intermediary in Uzbekistan to determine and finalize any required local approvals and establish essential partnerships with Doctors and Medical Facilities necessary for this testing once the Company's prototype is completed. The medical device is being developed by Cerebain Biotech Corp. as a potential new approach to the treatment for patients suffering from Alzheimer's and Dementia.

Eric Clemons, President, Cerebain Biotech Corp., said: "We are excited to have IDC Consulting representing us in Uzbekistan. They bring a wealth of local knowledge and relationships developed over time. Once our prototype is completed, we will begin to evaluate the device's efficacy and safety in human subjects. If successful, such trials may lead to the development of a new approach to the treatment of Alzheimer's Disease."

About Discount Dental Materials, Inc.

Discount Dental Materials, Inc. was incorporated in Nevada on December 17, 2007. The Company's business involves the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The Company's planned products include both a medical device solution as well as a synthetic drug solution. The Company's operations are conducted through its wholly-owned subsidiary, Cerebain Biotech Corp. For more information about Discount Dental and Cerebain Biotech, please visit the Company's website at www.cerebain.com and www.otcmarkets.com, under the ticker symbol "DDOO," to view the Company's public filings and stock quote.